ClinicalTrials.gg
RecruitingNCT04723498Updated May 13, 2025

Problematic Use of the Internet in Child and Adolescent Psychiatry

An interventional study of screening questionnaire in Substance Use Disorders, sponsored by Susanne Walitza. Recruiting at 1 site in Switzerland. Open to participants aged 8 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-13.

Sponsored by Susanne Walitza · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Dec 2020; still recruiting 5 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
8 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Substance-Related Disorders with a site in Switzerland — 6 open to participants now, 7 under way, none of them phase 3. Substance-Related Disorders · Switzerland.

Planned enrollment
4th of 23
300 · median 28
Started
2020
with 1 other
No phase
14 of 27
6 open now
Registered
21st of 27
by date

Among the 27 studies in Substance-Related Disorders with a site in Switzerland, this one is the 4th largest by planned enrollment of the 23 interventional ones that give a count, is one of 2 that started in 2020, is one of 14 with no phase, and was the 21st registered.

Substance-Related Disorders

2,242 studies on the registry are indexed under Substance-Related Disorders; 408 are open to participants now.

Browse Substance-Related Disorders studies →

Open to participants now

6 of the 27 studies in Substance-Related Disorders with a site in Switzerland are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 266 Substance-Related Disorders studies recruiting now, 130 (49%) set no upper age limit and 117 (44%) stop at 75 or younger; 55 take children under 18; 90 take healthy volunteers.

This study: 8 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Substance-Related Disorders with a site in Switzerland, or all of them as a file.
02

Study summary

Pathological internet use is a blanket term for problematic behavior types (e.g. uncontrolled gaming, cyber pornography, cyber mobbing and excessive use of social media): all perpetrated through the internet. There is little documentation or research on interdependencies/interplay between problematic internet and/or media use and child-adolescent disturbances. Very few clinical examples of syndromes like attention deficiency/hyperactivity (ADHS), anxiety disorder or affective disturbances associated with pathological media/internet use, or gaming, are found in literature.

03

Conditions studied

  • Substance Use Disorders
04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • male and female patients ages from 8 - 18 years
  • All study participants or their legal representative have given written permission for their experiences to be documented in the study.

Exclusion criteria

Exclusion Criteria:

  • Inability to understand explanations and the questionnaire, whether linguistic or cognitative
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Other
    Patients

    male and female patients, handled on an ambulatory basis in Psychiatric University Clinics, Department of Child and Adolescent Psychiatrythe ages from 8 - 18 years during the study

    Diagnostic Test: screening questionnaire

Interventions

  • Diagnostic testscreening questionnaire

    Fill in screening questionnaire

06

What researchers measure

Primary outcomes

  1. Symptoms severity of problematic internet and media use

    The clinician screening questionnaire (PUI) contains 9 items designed to assess severity of problematic internet and media use of obsessive and compulsive in children and adolescents.The test uses a 4-point scale to rate severity of problematic internet and media use. Higher score means a worse outcome.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2020 (actual). Primary completion is estimated for Mar 2026, 63 months after the start.

Of 819 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 63 months is above that.

Counting every sponsor, half of 859 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2021
First posted
Jan 25, 2021
StartActual
Dec 1, 2020
Primary completionEst.
Mar 1, 2026
CompletionEst.
Mar 1, 2026
Last update
May 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04723498
Lead sponsor
Susanne Walitza
Responsible party
Susanne Walitza (Head of the Department of Child and Adolescent Psychiatry, Psychiatric University Hospital, Zurich) — Sponsor-investigator
First posted
Jan 25, 2021
Start date
Dec 1, 2020
Primary completion
Mar 1, 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
May 13, 2025

Study contacts

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.
Contact
susanne.walitza@puk.zh.ch
+41 43 499 26 26
Renate Drechsler, Prof. Dr. phil.
Contact
renate.drechsler@kjpd.uzh.ch
+41 43 499 4050
Susanne Walitza, Prof. Dr. med. Dipl.-Psych.
principal investigator · Sponsor GmbH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion